Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5771103

CN(C)CC(C)(C)CNC(=O)CCc1cnoc1-c1ccc(C(F)(F)F)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.36
TRPV1 Q8NER1 7/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TP53 P04637 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
MAPT P10636 2/20 0.35
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
FFAR1 O14842 1/20 0.34
PPARA Q07869 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5775527 0.92 L3MBTL1 (0.36) HDAC4L3MBTL1TP53SMN1; SMN2LMNA
Trifluoroacetic Acid SCHEMBL5776657 0.86 MAPT (0.42) HDAC4TRPV1TP53SMN1; SMN2HPGD
Trifluoroacetic Acid SCHEMBL5772978 0.79 GSK3B (0.52) TRPV1SMN1; SMN2MAPTHDAC1HDAC2
Trifluoroacetic Acid SCHEMBL5772750 0.79 MAPT (0.40) TRPV1SMN1; SMN2LMNAHPGDMAPT
Trifluoroacetic Acid SCHEMBL5775717 0.79 GSK3B (0.44) TRPV1TP53SMN1; SMN2FFAR1MEN1
Trifluoroacetic Acid SCHEMBL5775554 0.79 HDAC4 (0.43) HDAC4TRPV1L3MBTL1TP53SMN1; SMN2
Trifluoroacetic Acid SCHEMBL5774050 0.78 TRPV1 (0.43) TRPV1TP53LMNAMAPTHDAC1
SCHEMBL5774001 0.78 FFAR1 (0.49) HDAC1HDAC2FFAR1PPARAHDAC8
Trifluoroacetic Acid SCHEMBL5777437 0.77 ACKR3 (0.41) HDAC4SMN1; SMN2LMNAHPGDMAPT
Trifluoroacetic Acid SCHEMBL5771101 0.77 TP53 (0.46) HDAC4TRPV1L3MBTL1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR HDAC4 434/4885TRPV1 2864/4885L3MBTL1 2718/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 HDAC4 497/4885TRPV1 3621/4885L3MBTL1 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.